Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

Biosimilar SB12 demonstrated comparable efficacy and safety for paroxysmal nocturnal hemoglobinuria (PNH) to its reference drug, showing similar outcomes across diverse patient groups.

Using a hybrid, closed-loop insulin delivery system in the auto mode shows improved glycemic control and a favorable safety ...

Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.

Low hemoglobin can leave you feeling tired, dizzy, and low on energy. But instead of turning to supplements first, why not ...

A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...

Red blood cells (RBCs) play a central role in keeping your body energized and functioning. They carry oxygen from your lungs ...

GRAND ISLAND, Neb. (KSNB) - The American Red Cross serving the Central & Western Nebraska region will offer a needle-free blood testing at their blood drives. The machines are called hemoglobin ...

In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful improvements in hemoglobin (Hb) levels ...